Top 20 Biopharma Deal Terminations of 2021 Based on Total Deal Value
March 10, 2022
Cytokinetics Initiates P-III (SEQUOIA-HCM) Trial of Aficamten for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyop...
February 24, 2022
Cytokinetics Presents Results of Omecamtiv Mecarbil in P-III (METEORIC-HF) Trial for Heart Failure with Reduced Ejection Fraction...
February 16, 2022
Cytokinetics Receives the US FDA Acceptance of NDA for Omecamtiv Mecarbil to Treat Heart Failure with Reduced Ejection Fraction
February 7, 2022
Cytokinetics Expands its Collaboration with Ji Xing to Develop and Commercialize Omecamtiv Mecarbil for HFrEF in Greater China
December 21, 2021
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value
February 11, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.